1. Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacteria-mediated transcription factors delivery.
- Author
-
Jin Y, Liu Y, Li Z, Santostefano K, Shi J, Zhang X, Wu D, Cheng Z, Wu W, Terada N, Jin S, and Bai F
- Subjects
- Cell Differentiation, Cell Line, Embryonic Stem Cells cytology, Embryonic Stem Cells metabolism, Humans, Induced Pluripotent Stem Cells metabolism, Myocytes, Cardiac metabolism, Plasmids genetics, Plasmids metabolism, Pseudomonas aeruginosa genetics, Transcription Factors genetics, Transcription Factors metabolism, Bacteria genetics, Cellular Reprogramming, Induced Pluripotent Stem Cells cytology, Myocytes, Cardiac cytology, Type III Secretion Systems genetics
- Abstract
Virus-mediated expression of defined transcription factor (TF) genes can effectively induce cellular reprogramming. However, sustained expression of the TFs often hinders pluripotent stem cell (PSC) differentiation into specific cell types, as each TF exerts its effect on PSCs for a defined period of time during differentiation. Here, we applied a bacterial type III secretion system (T3SS)-based protein delivery tool to directly translocate TFs in the form of protein into human PSCs. This transient protein delivery technique showed high delivery efficiency for hPSCs, and it avoids potential genetic alterations caused by the introduction of transgenes. In an established cardiomyocyte de novo differentiation procedure, five transcriptional factors, namely GATA4, MEF2C, TBX5, ESRRG and MESP1 (abbreviated as GMTEM), were translocated at various time points. By detecting the expression of cardiac marker genes (Nkx2.5 and cTnT), we found that GMTEM proteins delivered on mesoderm stage of the cardiomyocytes lineage differentiation significantly enhanced both the human ESC and iPSC differentiation into cardiomyocytes, while earlier or later delivery diminished the enhancing effect. Furthermore, all of the five factors were required to enhance the cardiac differentiation. This work provides a virus-free strategy of transient transcription factors delivery for directing human stem cell fate without jeopardizing genome integrity, thus safe for biomedical applications.
- Published
- 2018
- Full Text
- View/download PDF